Morningstar® Stock Report™

Boston Scientific Corp BSX

Balance Sheet Items (in % Terms)
20192020202120222023
Cash & Short Term Investments0.71%5.63%5.97%2.86%2.46%
Deudores5.98%4.97%5.52%6.07%6.34%
Existencias5.17%4.39%5.00%5.75%7.07%
Otros activos corrientes3.52%6.75%3.12%3.06%2.67%
Total activos corrientes15.37%21.75%19.60%17.74%18.54%
Net PP&E7.90%8.26%8.33%8.72%9.39%
Intangibles59.09%51.55%56.19%57.97%58.03%
Otros activos a largo plazo17.63%18.43%15.88%15.57%14.04%
Total Activo 100.00%100.00%100.00%100.00%100.00%
Accounts Payable1.77%1.67%2.46%2.65%2.68%
Deuda corriente4.63%0.04%0.81%0.06%1.51%
Impuestos a pagar0.87%0.51%0.65%0.71%0.63%
Accrued liabilities5.36%5.50%6.74%5.94%6.94%
Otro pasivo corriente3.29%4.23%2.60%2.34%2.28%
Total pasico corriente15.92%11.96%13.26%11.71%14.04%
Deuda a largo plazo28.11%29.63%27.29%27.44%24.38%
Otras deudas a largo plazo-----
Total Pasivo-----
Fondos propios totales45.40%49.80%51.58%54.13%54.88%
Total Liabilities and Equity100.00%100.00%100.00%100.00%100.00%
Liquidity/Financial Health
20192020202120222023
Current Ratio0.971.821.481.511.32
Quick Ratio0.440.890.870.760.63
Financial Leverage2.202.011.941.851.82
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures